跳至主要内容
临床试验/NCT02847715
NCT02847715已完成不适用

Electronic Patient Self-Reported Outcomes to Improve Cancer Management and Patient Experiences: Implement the System for Remote Monitoring of Cancer Patients in Remission

University of Leeds2 个研究点 分布在 1 个国家目标入组 143 人开始时间: 2016年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
143
试验地点
2
主要终点
Number of patients recruited / Number of patients approached (=consent rate)

研究概览

简要总结

Improvements in cancer treatment have led to an increasing number of patients being cured or in remission, but they are followed up to detect recurrence, manage persistent symptoms and late treatment effects. With growing survivors, traditional hospital follow-up is not sustainable. New models of follow-up care are needed. This research project aims to develop and establish the feasibility of introducing a new electronic care pathway/system for remote monitoring ovarian cancer patients in remission. The project includes a development phase, followed by an audit & pilot intervention phase to explore the feasibility of a new pathway/system for remote monitoring.

详细描述

Background Improvements in cancer treatment have led to an increasing number of patients being cured or in remission, but they are followed up to detect recurrence, manage persistent symptoms and late treatment effects. With growing survivors, traditional hospital follow-up is not sustainable. New models of follow-up care are needed.

Aim To develop and establish the feasibility of introducing a new electronic care pathway/system for remote monitoring ovarian cancer patients in remission.

Methods An existing online patient symptom reporting system will be extended for use in remote follow-up. A tracking program will be developed and IT systems integrated in the local hospitals.

Development Phase:

a) Scoping literature review of existing validated symptom measures. b) Consultation with expert groups to establish choice of questions, relevant symptoms, timing/frequency for monitoring. c) Interviews with patients and clinicians to explore current pathway and redesign.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Adult patients (aged 18 years or over) attending St James' University Hospital Bexley Wing, Bradford Teaching Hospitals NHS Foundation Trust, Calderdale & Huddersfield NHS Foundation Trust, and Airedale NHS Foundation Trust with stage 2-4 ovarian/fallopian/peritoneal/endometrial cancer in remission following the end of first or second line chemotherapy or end of maintenance Avastin/Bevacizumab (where indicated)
  • Patients may have recently completed treatment or already been on routine clinic-based face-to-face follow-up at the time of recruitment into the pilot intervention phase
  • Able and willing to give informed consent
  • Able to read and understand English
  • Access to the internet

排除标准

  • Exhibiting overt psychopathology/cognitive dysfunction
  • Taking part in other clinical trials involving the completion of extensive patient reported outcome or quality of life measures or requiring scheduled face-to-face clinical outpatient appointments (Intervention group only)

结局指标

主要结局

Number of patients recruited / Number of patients approached (=consent rate)

时间窗: Baseline

Number of patients recruited and number of patients approached will be logged by research team during recruitment (including reasons for non-recruitment)

Number of participants with self-reported symptom data (questionnaire) at 3 months

时间窗: 3 months

Patients will be reminded to complete an electronic questionnaire about their symptoms at 3 months

Number of participants with self-reported symptom data (questionnaire) at 9 months

时间窗: 9 months

Patients will be reminded to complete an electronic questionnaire about their symptoms at 9 months

Clinician acceptability (questionnaire/interviews)

时间窗: 12 months

Clinician acceptability explored through end-of-study questionnaires and interviews

Number of participants with self-reported symptom data (questionnaire) at 6 months

时间窗: 6 months

Patients will be reminded to complete an electronic questionnaire about their symptoms at 6 months

Reasons for participant withdrawals

时间窗: 12 months

Reasons for withdrawal will be assessed via case record form completed by researcher with the participant at time of withdrawal and collated at the end of the study

Number of participants with self-reported symptom data (questionnaire) at 12 months

时间窗: 12 months

Patients will be reminded to complete an electronic questionnaire about their symptoms at 12 months

Number of participant withdrawals

时间窗: 12 months

Number of participant withdrawals will be logged by research team at the time of any withdrawals

Patient acceptability (questionnaire/interviews)

时间窗: 12 months

Patient acceptability explored through end-of-study questionnaires and interviews

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Galina Velikova

Professor of Psycho-social and Medical Oncology/Consultant in Medical Oncology

University of Leeds

研究点 (2)

Loading locations...

相似试验